Tiapride in levodopa-induced involuntary movements.

AUTOR(ES)

Lees, A J

RESUMO

Tiapride, a substituted benzamide derivative closely related to metoclopramide, reduced levodopa-induced peak dose involuntary movements in 16 patients with idiopathic Parkinson's disease. However, an unacceptable increase in disability from Parkinsonism with aggravation of end-of-dose akinesia led to its cessation in 14 patients. Tiapride had no effect on levodopa-induced early morning of "off-period" segmental dystonia. These results fail to support the notion that levodopa-induced dyskinesias are caused by overstimulation of a separate group of dopamine receptors.

Documentos Relacionados

• Levodopa-induced dyskinesia and thalamotomy.
• Sodium valproate in the treatment of levodopa-induced dyskinesia.
• Metoclopramide and pimozide in Parkinson's disease and levodopa-induced dyskinesias.
• Levodopa‐induced dyskinesia in Parkinson's disease: clinical features, pathogenesis, prevention and treatment
• Low serum uric acid levels and levodopa-induced dyskinesia in Parkinson's disease